Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Remimazolam NeuroImaging

NCT: NCT07290205 · RECRUITING

NCT IDNCT07290205
StatusRECRUITING
Start Date2026-03-27
Completion2027-12-02

Brief Summary

This is a single-arm functional MRI study that will determine the effects of remimazolam on cognition and brain activity and connectivity at rest, during noxious stimulation, and during a memory encoding task

Frequently Asked Questions

What is Remimazolam NeuroImaging?

Remimazolam NeuroImaging is a clinical trial registered under NCT07290205. Current status: RECRUITING.

What is the status of NCT07290205?

The current status of NCT07290205 (Remimazolam NeuroImaging) is: RECRUITING.

When did Remimazolam NeuroImaging start?

Remimazolam NeuroImaging started on 2026-03-27.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑